EKF DIAGNOSTICS HOLDINGS PLC — Earnings Release 2017

Jul 6, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2483K

EKF Diagnostics Holdings PLC

06 July 2017

EKF Diagnostics Holdings plc

("EKF", the "Company")

Trading update

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, provides an update on current trading.

The Company is pleased to announce that the trading in the second quarter of the year has continued the favourable trends experienced in the first quarter.

In particular, June sales were notably strong. This is entirely due to organic growth with no major tenders won during the period.

As a consequence, the Company expects adjusted EBITDA for 2017 will be comfortably ahead of current market forecasts.

Finally, despite the cancellation of the stock option scheme at a cost of £1.5m cash generation has been very strong with net cash at 30 June of approximately £4.0m.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

EKF Diagnostics Holdings plc	www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman	Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker)	Tel: 020 7496 3000
Alex Price / Alex Laughton-Scott
Walbrook PR Limited	Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne	Mob: 07980 541 893 / 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLLFLRDTIEIID